蔡玉瑛

蔡玉瑛 (chief executive) discloses dealings in 拓新药业 to SSE / SZSE (CSRC). In total, 3 filings cover trades dated from 6 December 2022 to 15 December 2022.

Every open-market trade on record is a sale: 3 sales worth €1.7M.

The record was last updated on 15 December 2022 with an open-market sale (€105k) in 拓新药业. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.